Skip to content

the study Safety and Efficacy of Anti-Hair fall shampoo in comparison with Comparator Anti-Hair fall shampoo in subjects with very less to severe Hair fall

A Prospective study to evaluate the Safety and Efficacy of Investigational Anti-Hair fall shampoo in comparison with Comparator Anti-Hair fall shampoo in subjects with very less to severe Hair fall

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/06/014444
Enrollment
40
Registered
2018-06-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Dheedhi Anti hair fall herbal Shampoo: Dheedhi Anti hair fall herbal Shampoo Control Intervention1: Market comparator herbal Anti-Hair fall shampoo: Market comparator herbal Anti-Hair f

Sponsors

Dhathri Ayurveda Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Willingness to give written informed consent Subjects in the range of 18-50 years of age Subjects with very less to severe Hair fall. Willingness to discontinue any hair care product other than the IP throughout the study. Subjects who are not willing to color their hair throughout the treatment period Subjects willing to stop all the hair treatment such as hair spa, straightening, curling, perming, etc. Subjects with no skin allergies to any cosmetic products Willingness to follow the protocol requirements as evidenced by written informed consent Comprehension of the nature and purpose of the study and compliance with the requirement of the entire procedure In addition, female subjects selected for the study must be able to use a medically acceptable form of birth control during the study or be surgically sterile or be post-menopausal for at least 1 year.

Exclusion criteria

Exclusion criteria: 1. Subjects with known hypersensitivity to any specific ingredients of IPs 2. Subjects below the age of 18 years and subjects above 50 years 3. Subjects not willing to participate in the study 4. Subjects who have previously undergone hair transplantation procedures 5. Subjects with any skin diseases. 6. Subjects are being treated for hair fall or severe active infection of any type previously 7. Presence of any underlying significant uncontrolled medical illness involving the cardiovascular, respiratory, renal, gastrointestinal, hepatic, immunologic, hematological,endocrine, or nervous system s or psychiatric disease, HIV 8. Subjects with pre-existing scalp disorder such as scalp psoriasis, lichen planus, lichen planopilaris, DLE Discoid lupus erythematosus , sebopsoriasis will be excluded from the study 9. A female subject who is breast-feeding, pregnant, or intends to become pregnant during the study 10. Participating in a clinical research trial within 30 days prior to screening 11. Subjects who are cognitively impaired and/or who are unable to give informed consent. 12. Any other health or mental condition that in the Investigatorâ??s opinion may adversely affect the ability to complete the study or its measures or that may pose significant risk to the subject

Design outcomes

Primary

MeasureTime frame
Scales to rate over all experience of the study product with respect to the following 1) Hair fall Reduction 2) Hair damage control 3) New hair growth promotion 4) Cooling effect on scalp 5) Moisture maintenance 6) Management of Alopecia Timepoint: Visit 1 Day1 Visit 2 Day7 Visit 3 Day14 Visit 4 Day21 Visit 5 Day28 Visit 6 Day35 Visit 7 Day42

Secondary

MeasureTime frame
VAS Scales to rate over all experience of the study product with respect to the following: 1. Mildness 2. Non-irritant 3. Management of Seborrhea dermatitis 4. Texture of hair Timepoint: visit 7 Day42

Countries

India

Contacts

Public ContactPreeti A

Dhathri Ayurveda Pvt Ltd

doctor@dhathri.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026